Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB Antares Pharma.

South Korean authorities believe there is usually little risk to human beings and suspect the foundation virus was perhaps from migratory birds, tourist visitors, or the smuggling of livestock and produce from overseas.. Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB Antares Pharma, Inc. Best line data from this pivotal trial, which has been conducted under a Special Protocol Evaluation from the U.S. Food and Medication Administration , is expected in the 3rd quarter of the year. An interview with Professor Lesley JonesLenvatinib trial offers hope for thyroid cancer patientsAlport syndrome: an interview with Dr Paul Grint, CMO, Regulus Dr.S.While most fungal infections usually do not cause serious damage, if one spreads to the bloodstream it could be deadly. Hospitalized patients with catheters or central intravenous lines are at risk as the fungi can develop on those gadgets and enter your body. Similarly, patients with implanted medical products like pacemakers or prosthetic hips or knees are also at risk if the implant carries a fungus into the body. Also, people with compromised immune systems are at greater risk for critical fungal infections. Because of the lack of effective medications against C. Albicans and various other pathogenic fungi, the mortality price for systemic fungal attacks can be between 30 and 50 %.